A randomized, double blind clinical trial using the lipid lowering agent, Simvastatin, and the angiotensin converting enzyme inhibitor, Enalapril, to promote regression of coronary atherosclerosis.<\/p>\n
Contact Person:<\/strong> Publications:<\/strong> 2. Teo KK, Burton JR, Yokoyama S, Montague TJ for the Simvastatin\/Enalapril Coronary Atherosclerosis Trial (SCAT) Investigators. Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin converting enzyme inhibition on coronary atherosclerosis. Simvastatin\/Enalapril Coronary Atherosclerosis Trial (SCAT). Can J Cardiol 1997;13:591-602.<\/p>\n 3. Teo KK, Burton J, Buller C, Plante S, Catellier D, Tymchak W, Dzavik V, Taylor D, Yokoyama S, Montague TJ. Long-term effects of cholesterol lowering and angiotensin-converting Enzyme Inhibition on Coronary Atherosclerosis: The Simvastatin\/Enalapril Coronary Atherosclerosis Trial (SCAT). Circulation 2000;102:1748-1754.<\/p>\n","protected":false},"excerpt":{"rendered":" A randomized, double blind clinical trial using the lipid lowering agent, Simvastatin, and the angiotensin converting enzyme inhibitor, Enalapril, to promote regression of coronary atherosclerosis. Contact Person: Dr. Koon K. Teo Publications: 1. Koon K Teo MB PhD, Jeffrey R Burton MD, Joseph DeAlmeida PEng, Shelley Dolezsar BSc, Patricia A Montague BSc, Vladimir Dzavik MD, […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[31],"tags":[],"_links":{"self":[{"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/posts\/2849"}],"collection":[{"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/comments?post=2849"}],"version-history":[{"count":9,"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/posts\/2849\/revisions"}],"predecessor-version":[{"id":2869,"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/posts\/2849\/revisions\/2869"}],"wp:attachment":[{"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/media?parent=2849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/categories?post=2849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.epicore.ualberta.ca\/home\/wp-json\/wp\/v2\/tags?post=2849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nDr. Koon K. Teo<\/p>\n
\n1. Koon K Teo MB PhD, Jeffrey R Burton MD, Joseph DeAlmeida PEng, Shelley Dolezsar BSc, Patricia A Montague BSc, Vladimir Dzavik MD, Wayne J Tymchak MD, Dylan A Taylor MD, Terrence J Montague MD, for the Simvastatin\/Enalapril Coronary Athersclerosis Trial (SCAT) Investigators. Quantitative relation of electrocardiographic and angiocardiographic measures of risk in patients with coronary atherosclerosis. Can J Cardiol 1997;13:363-369.<\/p>\n